ZCA1 SRB-X (O1); june 6-7, 2019; DR. Saejeong KIM; bethesda north marriott; total hotel cost complies with HSS policy on promoting efficient spending as of 1/3/2012

Ended Awarded Last action

Contract number
75N91019F00139
Awardee
Awarding agency
Obligated
$16,077

Award facts

Contract value 100% obligated
$16,076.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines following NIH oalm communication 24-16 (20231204) -$786
Original award $16,863

About this award

The National Cancer Institute awarded a $16,076.95 firm fixed-price Blanket Purchase Agreement (BPA) call to Bsrep II MBN LLC, doing business as the Bethesda North Marriott Hotel & Conference Center, for a scientific peer review meeting held June 6-7, 2019, in Bethesda, Maryland. The award covered hotel accommodations and conference facilities for the ZCA1 SRB-X meeting led by Dr. Saejeong Kim. The contract was completed by March 26, 2024, and the hotel costs complied with Health and Human Services policy on efficient spending standards. No set-aside designation was used for this award.

Bsrep II MBN LLC is a subsidiary of Marriott International specializing in providing hospitality and conference services to federal agencies, with particular expertise supporting National Institutes of Health scientific meetings and peer review panels. The company has maintained an extensive contracting relationship with NIH institutes and other federal agencies since its SAM.gov registration in 2005, consistently delivering lodging, meeting spaces, and audiovisual support for grant review activities and scientific conferences. This award represents a standard competitive contract awarded through the BPA vehicle, reflecting the vendor's established capability in supporting government scientific operations.

Quick answers

Who was awarded contract 75N91019F00139?

75N91019F00139 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on June 6, 2019.

How much is contract 75N91019F00139 worth?

The government has obligated $16,077 on 75N91019F00139.

Is contract 75N91019F00139 an order under another contract?

Yes. 75N91019F00139 is a BPA call under HHSN263201500186B, a blanket purchase agreement.

Was contract 75N91019F00139 competed?

The extent of competition for 75N91019F00139 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award